🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 2a, placebo-controlled, single-blind study in up to 24 pati...
Status
Unknown
Location
Collaborative Neuroscience Network
Start Date
2018-09-10
Trial ID
NCT03642964
Treatments Being Tested
The objectives of the studies are: * To demonstrate similar total exposure...
Status
Completed
Location
Multiple Locations
Start Date
2006-04
Trial ID
NCT02261103
The main objective of the study is to explore firstly, then further evaluat...
Status
Completed
Location
Peking Union Medical College Hospital
Start Date
2018-07-03
Trial ID
NCT03521635
Treatments Being Tested
The objectives of this study were to investigate relative BA at steady stat...
Status
Completed
Location
Multiple Locations
Start Date
2006-09
Trial ID
NCT02264132
Treatments Being Tested
The objective of the study is to assess that pramipexole does not prolong t...
Status
Completed
Location
Multiple Locations
Start Date
2007-05
Trial ID
NCT02262546
The objective of this trial is to investigate the safety, tolerability, tro...
Status
Completed
Location
248.610.019 Boehringer Ingelheim Investigational Site
Start Date
2007-11
Trial ID
NCT00560508
Treatments Being Tested
Study to compare the oral bioavailability of seven prototype slow-release f...
Status
Completed
Location
Multiple Locations
Start Date
2004-06
Trial ID
NCT02261090
Treatments Being Tested
The primary objective of the study was to estimate the magnitude of the err...
Status
Completed
Location
Multiple Locations
Start Date
2005-10
Trial ID
NCT02260024
To establish bioequivalence at steady state of: 1)0.375 mg pramipexole ext...
Status
Completed
Location
248.665.86002 Boehringer Ingelheim Investigational Site
Start Date
2010-12
Trial ID
NCT01214109
To determine if there is any difference in the presence of retinal deterior...
Status
Completed
Location
248.538.00007 Boehringer Ingelheim Investigational Site
Start Date
2005-01
Trial ID
NCT00144300